Life
Briefing: Some top US lobbying firms are working both sides of the Pfas issue at the same time
Strategic angle: Review from non-profit finds range of scenarios of firms simultaneously lobbying for and against Pfas regulations.
editorial-staff
1 min read
Updated 28 days ago
A non-profit review has uncovered that leading US lobbying firms are simultaneously representing interests both for and against regulations concerning Pfas, commonly known as 'forever chemicals.'
This dual engagement raises significant questions about the integrity of advocacy efforts and the potential conflicts of interest inherent in such practices.
The implications for regulatory frameworks are substantial, as these firms may influence policy outcomes in ways that do not align with public health objectives.